Clincosm LogoSign in Get a demo

Metastatic Melanoma

Showing 76 - 100 of 296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Intestinal and Salivary Microbiota Biobank - Oncologic

Completed
  • Non Small Cell Lung Cancer
  • Metastatic Melanoma
  • Biological sample collection
  • +2 more
  • Bari, Italy
    IRCCS Istituto Tumori Giovanni Paolo II
Aug 3, 2022

Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Imatinib Mesylate
  • Ipilimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +19 more
Aug 1, 2022

Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Ibrutinib,

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +2 more
  • Los Angeles, California
  • +12 more
Jul 27, 2022

Metastatic Melanoma, BRAF Gene Mutation Trial in Lexington (Nilotinib 100mg, Nilotinib 200mg, Nilotinib 300mg)

Recruiting
  • Metastatic Melanoma
  • BRAF Gene Mutation
  • Nilotinib 100mg
  • +5 more
  • Lexington, Kentucky
    Markey Cancer Center
Jul 22, 2022

Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)

Terminated
  • Metastatic Melanoma
  • Tumor Infiltrating Lymphocytes
  • Nivolumab and Ipilimumab
  • New Haven, Connecticut
    Yale New Haven Hospital
Jul 20, 2022

Unresectable Melanoma, Metastatic Melanoma Trial in Orlando, Louisville, New York (Lifileucel)

Available
  • Unresectable Melanoma
  • Metastatic Melanoma
  • Lifileucel
  • Orlando, Florida
  • +2 more
Jul 19, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Hematopoietic and Lymphoid Cell Tumor

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +13 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

Recruiting
  • Unresectable Melanoma
  • +3 more
  • Sargramostim (GM-CSF)
  • Pembrolizumab (anti-PD-1)
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Metastatic Melanoma Trial in United States (Placebo for antibiotic, Vancomycin pretreatment, Nivolumab)

Completed
  • Metastatic Melanoma
  • Placebo for antibiotic
  • +4 more
  • Los Angeles, California
  • +6 more
Jun 7, 2022

Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients

Recruiting
  • Melanoma (Skin)
  • +2 more
    • Evora, Portugal
      Hospital Evora
    May 30, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +3 more
    • Ipilimumab
    • Nivolumab
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    May 6, 2022

    Melanoma, Melanoma Stage IV, Metastatic Melanoma Trial in Gothenburg (Surgical metastasectomy, Immunotherapy)

    Recruiting
    • Melanoma
    • +3 more
    • Gothenburg, Sweden
      Sahlgrenska University Hospital
    May 3, 2022

    Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

    Recruiting
    • Clinical Stage I Cutaneous Melanoma AJCC v8
    • +8 more
    • Ipilimumab
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 28, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +129 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Apr 8, 2022

    Metastatic Melanoma Trial in Boston (Pembrolizumab, Infliximab, Placebo)

    Recruiting
    • Metastatic Melanoma
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Apr 6, 2022

    Metastatic Melanoma Trial in Darlinghurst, Sydney, Brisbane (Palliative radiotherapy, Dabrafenib and trametinib (combination))

    Completed
    • Metastatic Melanoma
    • Palliative radiotherapy
    • Dabrafenib and trametinib (combination)
    • Darlinghurst, New South Wales, Australia
    • +2 more
    Apr 6, 2022

    Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

    Recruiting
    • Advanced Differentiated Thyroid Gland Carcinoma
    • +102 more
    • Cabozantinib S-malate
    • Nivolumab
    • Chicago, Illinois
    • +2 more
    Apr 5, 2022

    Malignant Melanoma, Metastatic Melanoma, Immunotherapy Trial (Pembrolizumab, Encorafenib, Binimetinib)

    Not yet recruiting
    • Malignant Melanoma
    • +4 more
    • (no location specified)
    Mar 31, 2022

    Metastatic Melanoma Trial in United States (IN10018, Cobimetinib)

    Recruiting
    • Metastatic Melanoma
    • Miami, Florida
    • +4 more
    Mar 29, 2022

    Metastatic Melanoma Trial in Lancaster, Philadelphia (Hypofractionated Radiation Therapy (HFRT), Nivolumab, Ipilimumab)

    Recruiting
    • Metastatic Melanoma
    • Hypofractionated Radiation Therapy (HFRT)
    • +2 more
    • Lancaster, Pennsylvania
    • +1 more
    Mar 30, 2022